Back

Twist Bioscience shares rise 5.79% on Lilly TuneLab agreement

Verifying
  • Twist Bioscience agreed to provide antibody characterization services for Lilly TuneLab users.
  • Twist shares rose 5.79% to $146.09, approaching a $155.44 52-week high.
  • Anthropic selected Twist in August to independently evaluate an artificial-intelligence protein design campaign.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.